Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-006593
Filing Date
2025-09-02
Accepted
2025-09-02 16:05:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4391
  Complete submission text file 0001950047-25-006593.txt   5866
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Subject) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42513 | Film No.: 251285433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 HARBOURFRONT AVENUE, #16-06 KEPPEL BAY TOWER SINGAPORE U0 098632
Business Address
Tan Finian (Reporting) CIK: 0002057336 (see all company filings)

Type: 144